If i were to take a positive, the production cost coming away from the optimal price output is not too bad. With CAPEX winding down, we could still expect an improvement on the next quarter.
The realised price? Horrible!
Cash balance?... Horrible?
I havent read the whole report yet, but if we are indeed owed cash, why arent we being paid it? what tricks is the banker up to now? Why decimate the sentiment around the producer partner any further?
- Forums
- ASX - By Stock
- SYA
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-45
Featured News
Add SYA (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.001(3.03%) |
Mkt cap ! $349.9M |
Open | High | Low | Value | Volume |
3.3¢ | 3.5¢ | 3.2¢ | $1.311M | 38.83M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 2780304 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 10659292 | 48 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 2780304 | 0.034 |
21 | 15165950 | 0.033 |
32 | 11939293 | 0.032 |
30 | 11907884 | 0.031 |
77 | 20131815 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 10512284 | 46 |
0.036 | 11730260 | 46 |
0.037 | 9532973 | 44 |
0.038 | 10048257 | 34 |
0.039 | 1640991 | 14 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
SYA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online